SCHEMBL8852258

SCHEMBL8852258

CN(CCCN)C1CC[N]CC1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.32
HRH3 Q9Y5N1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8851859 0.88
SCHEMBL6967400 0.85
SCHEMBL24654499 0.83 CHRM2 (0.37) CHRM2HRH3
SCHEMBL8851109 0.82 ALDH1A1 (0.35)
SCHEMBL4687426 0.82 SMN1; SMN2 (0.35)
SCHEMBL3323907 0.79 HRH4 (0.40) CHRM2HRH3
SCHEMBL6961851 0.79 CHRM2 (0.48) CHRM2
SCHEMBL13744684 0.78 CHRM2 (0.33) CHRM2
SCHEMBL8852107 0.77 PRMT3 (0.32)
SCHEMBL8851306 0.77 KDM4E (0.41) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5618814-A Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds DR. KARL THOMAE GMBH (DE) 1997-04-08 US disclosed
EP-0645390-A1 Trisubstituted pyrimido 5,4-d pyrimidines for modulating multidrug resistance, drugs containing these compounds and processes for their preparation Dr. Karl Thomae GmbH (DE) 1995-03-29 EP disclosed